| Stock Name | Lyell Immunopharma Inc |
| Ticker | LYEL(USD) NASDAQ |
| TYPE | Common Stock |
| Country | USA |
| ISIN | US55083R1041 |
The adjusted close for LYEL on 2025-11-11 was 17.25
The following institutional investment holdings of LYEL have been identified
| Date | ETF ISIN/Name | Num Shares | Book value | Derived Price per Share | Comment |
|---|---|---|---|---|---|
| 2025-11-11 | IE00BYXG2H39 (iShares Nasdaq US Biotechnology UCITS ETF USD (Acc)) | 12,354 | USD 213,107 | 17.25 ![]() | |
| 2025-11-11 | IE00BDZVHG35 (iShares Nasdaq US Biotechnology UCITS ETF USD (Dist)) | 12,354 | USD 213,107 -2.5% | 17.25 ![]() | |
| Total = | 24,708 | USD 426,214 | |||